相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer
Christel Haggstrom et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Metformin induces degradation of cyclin D1 via AMPK/GSK3 axis in ovarian cancer
HyeRan Gwak et al.
MOLECULAR CARCINOGENESIS (2017)
Cancer metabolism: a therapeutic perspective
Ubaldo E. Martinez-Outschoorn et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Pharmacological Targeting of AMP-Activated Protein Kinase and Opportunities for Computer-Aided Drug Design
Marie Miglianico et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Metformin Has a Positive Therapeutic Effect on Prostate Cancer in Patients With Type 2 Diabetes Mellitus
R. William Chong et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2016)
Compound C inhibits macrophage chemotaxis through an AMPK-independent mechanism
Youngyi Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators
Kimberly O. Cameron et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Combinational strategies of metformin and chemotherapy in cancers
Hui-Hui Zhang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Combining p53 stabilizers with metformin induces synergistic apoptosis through regulation of energy metabolism in castration- resistant prostate cancer
Long Chen et al.
CELL CYCLE (2016)
Does Metformin Reduce Cancer Risks? Methodologic Considerations
Asieh Golozar et al.
CURRENT DIABETES REPORTS (2016)
Androgen control of lipid metabolism in prostate cancer: novel insights and future applications
Lisa M. Butler et al.
ENDOCRINE-RELATED CANCER (2016)
AMP-activated protein kinase: a cellular energy sensor that comes in 12 flavours
Fiona A. Ross et al.
FEBS JOURNAL (2016)
Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy
Kimberly O. Cameron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
AMPK Causes Cell Cycle Arrest in LKB1-Deficient Cells via Activation of CAMKK2
Sarah Fogarty et al.
MOLECULAR CANCER RESEARCH (2016)
Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells
Simeng Wen et al.
MOLECULAR CARCINOGENESIS (2016)
Glucose Alters Per2 Rhythmicity Independent of AMPK, Whereas AMPK Inhibitor Compound C Causes Profound Repression of Clock Genes and AgRP in mHypoE-37 Hypothalamic Neurons
Johanneke E. Oosterman et al.
PLOS ONE (2016)
Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments
Barrie Peck et al.
CANCER & METABOLISM (2016)
AMPK activators: mechanisms of action and physiological activities
Joungmok Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38
Valentina Grossi et al.
AUTOPHAGY (2015)
Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?
R. Brooks Robey et al.
CARCINOGENESIS (2015)
Targeting the 5′-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer
Petra Popovics et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Metformin Effects on Biochemical Recurrence and Metabolic Signaling in the Prostate
Brian Winters et al.
PROSTATE (2015)
Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients
Jianlei Lu et al.
MEDICAL SCIENCE MONITOR (2015)
Small Molecule Adenosine 5′-Monophosphate Activated Protein Kinase (AMPK) Modulators and Human Diseases
Sandeep Rana et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle
S. M. Hadad et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
Giorgia Zadra et al.
EMBO MOLECULAR MEDICINE (2014)
Synergistic Simvastatin and Metformin Combination Chemotherapy for Osseous Metastatic Castration-Resistant Prostate Cancer
Melissa A. Babcook et al.
MOLECULAR CANCER THERAPEUTICS (2014)
The AMPK Inhibitor Compound C Is a Potent AMPK-Independent Antiglioma Agent
Xiaona Liu et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms
Matthew F. Calabrese et al.
STRUCTURE (2014)
Transcriptomic analysis reveals inhibition of androgen receptor activity by AMPK in prostate cancer cells
Sarah Jurmeister et al.
ONCOTARGET (2014)
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
Madhumita Dandapani et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
The fat side of prostate cancer
Giorgia Zadra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Estimation of rat mammary tumor volume using caliper and ultrasonography measurements
Ana Faustino-Rocha et al.
LAB ANIMAL (2013)
Development of Novel Alkene Oxindole Derivatives As Orally Efficacious AMP-Activated Protein Kinase Activators
Li-Fang Yu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Structural basis of AMPK regulation by small molecule activators
Bing Xiao et al.
NATURE COMMUNICATIONS (2013)
Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation
Ian P. Salt et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan
Antero Salminen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
SU11248 (sunitinib) directly inhibits the activity of mammalian 5′-AMP-activated protein kinase (AMPK)
Keith R. Laderoute et al.
CANCER BIOLOGY & THERAPY (2010)
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
Issam Ben Sahra et al.
CANCER RESEARCH (2010)
Highly Enantioselective and Organocatalytic α-Amination of 2-Oxindoles
Liang Cheng et al.
ORGANIC LETTERS (2009)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper
Mette Munk Jensen et al.
BMC MEDICAL IMAGING (2008)
Convenient fluorination of nitro and nitrile compounds with Selectfluor
WM Peng et al.
TETRAHEDRON LETTERS (2005)
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
RG Jones et al.
MOLECULAR CELL (2005)
Selectfluor: Mechanistic insight and applications
PT Nyffeler et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Enantioselective synthesis of (-)-idiospermuline
LE Overman et al.
TETRAHEDRON (2003)
分享论文
